We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

76 hedge funds and large institutions have $284M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

83% more capital invested

Capital invested by funds: $155M → $284M (+$129M)

69% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 16

43% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 14

9% more funds holding

Funds holding: 70 → 76 (+6)

Holders
76
Holders Change
+6
Holders Change %
+8.57%
% of All Funds
1.99%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
20
Increased
27
Reduced
16
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.88M
2
CAM
Cormorant Asset Management
Massachusetts
+$8.58M
3
BFA
BlackRock Fund Advisors
California
+$3.72M
4
DCM
Driehaus Capital Management
Illinois
+$3.34M
5
CS
Candriam SCA
Luxembourg
+$1.83M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.55M
2
BI
BVF Inc
California
-$4.33M
3
JP Morgan Chase
JP Morgan Chase
New York
-$2.69M
4
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$2.4M
5
HLA
Hamilton Lane Advisors
Pennsylvania
-$1.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$1.97M -$11.5K -836 -0.8%
ARTA
27
A.R.T. Advisors
New York
$1.41M +$1.07M +77,966 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$1.36M +$1.57K +114 +0.2%
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$1.33M +$1.01M +73,607 New
OM
30
Opaleye Management
Massachusetts
$1.06M +$805K +58,500 New
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
$908K -$1.3M -94,128 -65%
FSA
32
Franklin Street Advisors
North Carolina
$905K – – –
BIM
33
BlackRock Investment Management
Delaware
$831K +$1.76K +128 +0.3%
TCIM
34
TIAA CREF Investment Management
New York
$823K +$118K +8,594 +23%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$760K +$25.4K +1,847 +5%
NFA
36
Nationwide Fund Advisors
Ohio
$725K -$221K -16,025 -29%
ACM
37
Atika Capital Management
New York
$724K -$68.8K -5,000 -11%
GAMA
38
Graticule Asia Macro Advisors
New York
$721K -$897K -65,200 -62%
Handelsbanken Fonder
39
Handelsbanken Fonder
Sweden
$688K +$523K +38,000 New
Charles Schwab
40
Charles Schwab
California
$590K +$70.6K +5,128 +19%
AA
41
ALPS Advisors
Colorado
$521K -$74.2K -5,394 -16%
HLA
42
Hamilton Lane Advisors
Pennsylvania
$499K -$1.97M -143,355 -84%
RP
43
Rowlandmiller & Partners
Georgia
$457K +$61.7K +4,487 New
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$446K -$2.4M -174,234 -88%
Citadel Advisors
45
Citadel Advisors
Florida
$443K +$337K +24,495 New
PC
46
Polar Capital
United Kingdom
$409K +$49.5K +3,597 +19%
TA
47
Teachers Advisors
New York
$385K +$26.5K +1,924 +10%
NC
48
Nexthera Capital
New York
$375K +$285K +20,720 New
ProShare Advisors
49
ProShare Advisors
Maryland
$353K +$269K +19,516 New
SO
50
STRS Ohio
Ohio
$342K – – –
1
2
3 4

VTAE Hedge Fund Activity: Q4 2015 in Review

76 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q4 2015, worth a combined $284M — up 83% from $155M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VTAE positions and 14 closed out — a net gain of 6 holders — while 27 added to existing stakes and 16 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $9.88M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $6.55M sold.

  • 76 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q4 2015, up from 70 in Q3 2015.
  • Funds reported $284M of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q4 2015, up 83% quarter-over-quarter.
  • 20 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q4 2015 and 14 closed out, a net change of +6 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK buyer in Q4 2015 was Adage Capital Partners, an estimated $9.88M added.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q4 2015 was Point72 Asset Management, an estimated $6.55M sold.

Based on aggregated 13F filings for Q4 2015.